Peptide record

TPDB09628

Maximin H1 Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09628
Maximin H1
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP dbAMP 3.0 iACP-DRLF pep-lab AFP-GFuse Antifungipept CAFPdb AI4AVP DRAVP 2.0 APD_complete PD_Hemolysis ToxinPred 3.0
standard
No
A 20-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
ILGPVISTIGGVLGGLLKNL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C90H160N22O24
ARDCEQHMFWY
GL
1934.39
10.10
1
0
10
+1
-1.70
1.420
185.00
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
0
0.00
3
Residue Composition
number
0
A
0
R
1
N
0
D
0
C
0
E
0
Q
5
G
0
H
3
I
5
L
1
K
0
M
0
F
1
P
1
S
1
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 0 R: 0 N: 1 D: 0 C: 0 E: 0 Q: 0 G: 5 H: 0 I: 3 L: 5 K: 1 M: 0 F: 0 P: 1 S: 1 T: 1 W: 0 Y: 0 V: 2
Chemical Descriptors
20 reviewed residue count
C90H160N22O24 sequence-only estimate (linear, free termini)
1934.39 sequence-only estimate (linear, free termini)
10.10 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
-1.70 sequence-only estimate (linear, free termini)
1.420 sequence-only estimate (linear, free termini)
Free Activity
L Activity
Not Available Activity
Free Activity
Antibacterial Activity
Bombina maxima Activity
Evidence Records 13 records
Evidence 1 Activity

Activity

MIC
Antibacterial
9 µg/mL

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli ATCC25922 (MIC 9 ug/ml), S. aureus ATCC2592 (4.5 ug/ml), B. pyocyaneus CMCCB1010 (9 ug/ml), B.dysenteriae (not de
Evidence 2 Activity

Activity

MIC
Antibacterial
4.5 µg/mL

Target

Candida albicans ATCC2002

Source & Reference

dbAMP DRAMP

Other

(4.5 ug/ml), B. pyocyaneus CMCCB1010 (9 ug/ml), B.dysenteriae (not detectable), and fungi C. albicans ATCC2002 (MIC 4.5 ug/ml) (Lai R et al., 2012) . Updated 12/2015 11/2024.
Evidence 3 Activity

Activity

Not Available
Anticancer

Target

Not Available
Not Available
Not Available

Assay & Model

Not Available
Not Available

Source & Reference

dbAMP 3.0 CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2002

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation. dbAMP 3.0 classified as Anticancer under the disease-associated peptide function classes.
Evidence 4 Activity

Activity

MIC
Antifungal
9 µg/mL

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli ATCC25922 (MIC 9 ug/ml), S. aureus ATCC2592 (4.5 ug/ml), B. pyocyaneus CMCCB1010 (9 ug/ml), B.dysenteriae (not de
Evidence 5 Activity

Activity

MIC
Antifungal
4.5 µg/mL

Target

Candida albicans ATCC2002

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(4.5 ug/ml), B. pyocyaneus CMCCB1010 (9 ug/ml), B.dysenteriae (not detectable), and fungi C. albicans ATCC2002 (MIC 4.5 ug/ml) (Lai R et al., 2012) . Updated 12/2015 11/2024.
Evidence 6 Activity

Activity

MIC
Antiparasitic
9 µg/mL

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Active against E. coli ATCC25922 (MIC 9 ug/ml), S. aureus ATCC2592 (4.5 ug/ml), B. pyocyaneus CMCCB1010 (9 ug/ml), B.dysenteriae (not de
Evidence 7 Activity

Activity

MIC
Antiparasitic
4.5 µg/mL

Target

Candida albicans ATCC2002

Source & Reference

dbAMP 3.0 DRAMP

Other

(4.5 ug/ml), B. pyocyaneus CMCCB1010 (9 ug/ml), B.dysenteriae (not detectable), and fungi C. albicans ATCC2002 (MIC 4.5 ug/ml) (Lai R et al., 2012) . Updated 12/2015 11/2024.
Evidence 8 Activity

Activity

MIC
Antiviral
9 µg/mL

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
Active against E. coli ATCC25922 (MIC 9 ug/ml), S. aureus ATCC2592 (4.5 ug/ml), B. pyocyaneus CMCCB1010 (9 ug/ml), B.dysenteriae (not de
Evidence 9 Activity

Activity

MIC
Antiviral
4.5 µg/mL

Target

Candida albicans ATCC2002

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

(4.5 ug/ml), B. pyocyaneus CMCCB1010 (9 ug/ml), B.dysenteriae (not detectable), and fungi C. albicans ATCC2002 (MIC 4.5 ug/ml) (Lai R et al., 2012) . Updated 12/2015 11/2024.
Evidence 10 Activity

Activity

% Hemolysis
Hemolysis
100 %
[Ref:11835991]90–100% hemolytic activity at 50 µg/ml against rabbit red blood cells

Target

rabbit red blood cells

Source & Reference

Hemolytik APD_complete PD_Hemolysis
DRAMP4
Eur J Immunol. 2005 Apr 35(4):1220-9.##Peptides. 2002 Mar 23(3):427-435.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 11 Activity

Activity

100% Hemolysis
Toxicity
50 µg/mL
Hemolytic Cytotoxic
100% Hemolysis | 50 | µg/mL | target cell: Rabbit erythrocytes

Target

Rabbit erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima. | Peptides | 2002
Evidence 12 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref:11835991]90–100% hemolytic activity at 50 µg/ml against rabbit red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Eur J Immunol. 2005 Apr 35(4):1220-9.##Peptides. 2002 Mar 23(3):427-435.
Evidence 13 Hemolysis

Activity

100 %
% Hemolysis
[Ref:11835991]90–100% hemolytic activity at 50 µg/ml against rabbit red blood cells
Hemolysis

Target

rabbit red blood cells

Source & Reference

APD_complete PD_Hemolysis
Eur J Immunol. 2005 Apr 35(4):1220-9.##Peptides. 2002 Mar 23(3):427-435.
DRAMP4
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.